See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy
Publications for Andrea Cervi
Updated daily
Loading publication list...
| # | PubMedId | Deleted | Publication |
|---|---|---|---|
| 1 | 39268016 | 0 | Ladak R, Sementilli M, Calandra J, et al. Physician practice patterns on the use of inferior vena cava filters in venous thromboembolism. Res Pract Thromb Haemost. 2024 Aug 5;8(6):102540. doi: 10.1016/j.rpth.2024.102540. eCollection 2024 Aug. |
| 2 | 38702341 | 0 | Fontyn S, Bai Y, Bolger S, et al. Inferior vena cava filter use at a large community hospital: a retrospective cohort study. Sci Rep. 2024 May 3;14(1):10192. doi: 10.1038/s41598-024-60868-z. |
| 3 | 37984078 | 0 | Wang TF, Delluc A, Cervi A, et al. A survey of clinician perspectives on the management of catheter-related upper extremity deep vein thrombosis in patients with cancer. Thromb Res. 2024 Jan;233:10-13. doi: 10.1016/j.thromres.2023.11.012. Epub 2023 Nov 16. |
| 4 | 34963615 | 0 | Cook O, Cervi A, Laureano M, et al. Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease. Transfus Apher Sci. 2022 Jun;61(3):103345. doi: 10.1016/j.transci.2021.103345. Epub 2021 Dec 16. |
| 5 | 32219982 | 0 | Mithoowani S, Cervi A, Shah N, et al. Management of major bleeds in patients with immune thrombocytopenia. J Thromb Haemost. 2020 Jul;18(7):1783-1790. doi: 10.1111/jth.14809. Epub 2020 May 6. |
| 6 | 31705519 | 0 | Cervi A, Douketis JD. Stent Thrombosis after Endovascular Treatment of Iliofemoral or Caval Veins in Patients with Postthrombotic Syndrome. Thromb Haemost. 2019 Dec;119(12):1897-1899. doi: 10.1055/s-0039-1700808. Epub 2019 Nov 8. |
| 7 | 31239247 | 0 | Douketis J, Cervi A. Managing patients who are receiving warfarin or a direct oral anticoagulant and need an elective surgery or procedure. Blood Adv. 2019 Jun 25;3(12):1925. doi: 10.1182/bloodadvances.2019000171. |
| 8 | 31207620 | 0 | Cervi A, Douketis J. In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days. Ann Intern Med. 2019 Jun 18;170(12):JC67. doi: 10.7326/ACPJ201906180-067. |
| 9 | 30296870 | 0 | Cervi A, Crowther M. Andexanet alfa for the treatment of hemorrhage. Expert Rev Hematol. 2018 Nov;11(11):847-855. doi: 10.1080/17474086.2018.1532287. Epub 2018 Oct 17. |
| 10 | 30054799 | 0 | Cervi A, Douketis JD. Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016-2017. Intern Emerg Med. 2019 Apr;14(3):355-363. doi: 10.1007/s11739-018-1910-2. Epub 2018 Jul 27. |
, McMaster University